{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:13:12Z","timestamp":1777259592443,"version":"3.51.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T00:00:00Z","timestamp":1268697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T00:00:00Z","timestamp":1268697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1038\/cr.2010.32","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T11:41:42Z","timestamp":1268739702000},"page":"400-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Polyglutamine toxicity in non-neuronal cells"],"prefix":"10.1038","volume":"20","author":[{"given":"Jennifer W","family":"Bradford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,16]]},"reference":[{"key":"BFcr201032_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi HY, Orr HT . Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000; 23:217\u2013247.","journal-title":"Annu Rev Neurosci"},{"key":"BFcr201032_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-1-19","volume":"1","author":"SH Li","year":"2006","unstructured":"Li SH, Li XJ . Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegeneration 2006; 1:19.","journal-title":"Mol Neurodegeneration"},{"key":"BFcr201032_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2337\/db08-0799","volume":"58","author":"B Martin","year":"2009","unstructured":"Martin B, Golden E, Carlson OD, et al. Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease. Diabetes 2009; 58:318\u2013328.","journal-title":"Diabetes"},{"key":"BFcr201032_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","volume":"8","author":"JM van der Burg","year":"2009","unstructured":"van der Burg JM, Bj\u00f6rkqvist M, Brundin P . Beyond the brain: widespread pathology in Huntington's disease. Lancet Neurol 2009; 8:765\u2013774.","journal-title":"Lancet Neurol"},{"issue":"6","key":"BFcr201032_CR5","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"M MACDONALD","year":"1993","unstructured":"The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72:971\u2013983.","journal-title":"Cell"},{"key":"BFcr201032_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","volume":"330","author":"B Kremer","year":"1994","unstructured":"Kremer B, Goldberg P, Andrew SE, et al. World wide distribution of the Huntington disease (HD) mutation: The sensitivity and specificity of CAG repeat length assessment. New Engl J Med 1994; 330:1401\u20131406.","journal-title":"New Engl J Med"},{"key":"BFcr201032_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP . Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44:559\u2013577.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFcr201032_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/81593","volume":"26","author":"I Dragatsis","year":"2000","unstructured":"Dragatsis I, Levine MS, Zeitlin S . Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet 2000; 26:300\u2013306.","journal-title":"Nat Genet"},{"key":"BFcr201032_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","volume":"28","author":"P Harjes","year":"2003","unstructured":"Harjes P, Wanker E . The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 2003; 28:425\u2013433.","journal-title":"Trends Biochem Sci"},{"key":"BFcr201032_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"SH Li","year":"2004","unstructured":"Li SH, Li XJ . Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet 2004; 20:146\u2013154.","journal-title":"Trends Genet"},{"key":"BFcr201032_CR11","doi-asserted-by":"publisher","first-page":"12784","DOI":"10.1073\/pnas.221451398","volume":"98","author":"YJ Kim","year":"2001","unstructured":"Kim YJ, Yi Y, Sapp E, et al. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci USA 2001; 98:12784\u201312789.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr201032_CR12","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","volume":"22","author":"J Gafni","year":"2002","unstructured":"Gafni J, Ellerby LM . Calpain activation in Huntington's disease. J Neurosci 2002; 22:4842\u20134849.","journal-title":"J Neurosci"},{"key":"BFcr201032_CR13","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","volume":"22","author":"CL Wellington","year":"2002","unstructured":"Wellington CL, Ellerby LM, Gutekunst CA, et al. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J Neurosci 2002; 22:7862\u20137872.","journal-title":"J Neurosci"},{"key":"BFcr201032_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","volume":"10","author":"A Lunkes","year":"2002","unstructured":"Lunkes A, Lindenberg KS, Ben-Ha\u00efem L, et al. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell 2002; 10:259\u2013269.","journal-title":"Mol Cell"},{"key":"BFcr201032_CR15","first-page":"1243","volume":"25","author":"ZH Qin","year":"2004","unstructured":"Qin ZH, Gu ZL . Huntingtin processing in pathogenesis of Huntington disease. Acta Pharmacol Sin 2004; 25:1243\u20131249.","journal-title":"Acta Pharmacol Sin"},{"key":"BFcr201032_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","volume":"14","author":"M DiFiglia","year":"1995","unstructured":"DiFiglia M, Sapp E, Chase K, et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 1995; 14:1075\u20131081.","journal-title":"Neuron"},{"key":"BFcr201032_CR17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","volume":"14","author":"AH Sharp","year":"1995","unstructured":"Sharp AH, Loev SJ, Schilling G, et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 1995; 14:1065\u20131074.","journal-title":"Neuron"},{"key":"BFcr201032_CR18","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997; 277:1990\u20131993.","journal-title":"Science"},{"key":"BFcr201032_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrn1386","volume":"5","author":"MF Beal","year":"2004","unstructured":"Beal MF, Ferrante R . Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat Rev 2004; 5:373\u2013384.","journal-title":"Nat Rev"},{"key":"BFcr201032_CR20","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/WCO.0b013e3281fbd3dd","volume":"20","author":"BW Soong","year":"2007","unstructured":"Soong BW, Paulson HL . Spinocerebellar ataxias: an update. Curr Opin Neurol 2007; 20:438\u2013446.","journal-title":"Curr Opin Neurol"},{"key":"BFcr201032_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ng1193-254","volume":"5","author":"MY Chung","year":"1993","unstructured":"Chung MY, Ranum LP, Duvick LA, Servadio A, Zoghbi HY, Orr HT . Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I. Nat Genet 1993; 5:254\u2013258.","journal-title":"Nat Genet"},{"key":"BFcr201032_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng1196-285","volume":"14","author":"G Imbert","year":"1996","unstructured":"Imbert G, Saudou F, Yvert G, et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG\/glutamine repeats. Nat Genet 1996; 14:285\u2013291.","journal-title":"Nat Genet"},{"key":"BFcr201032_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molcel.2005.02.030","volume":"18","author":"JM Warrick","year":"2005","unstructured":"Warrick JM, Morabito LM, Bilen J, et al. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol Cell 2005; 18:37\u201348.","journal-title":"Mol Cell"},{"key":"BFcr201032_CR24","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/hmg\/ddl080","volume":"15","author":"HB Kordasiewicz","year":"2006","unstructured":"Kordasiewicz HB, Thompson RM, Clark HB, Gomez CM . C-termini of P\/Q-type Ca21 channel a1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity. Hum Mol Genet 2006; 15:1587\u20131599.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR25","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/hmg\/7.11.1809","volume":"7","author":"G Stevanin","year":"1998","unstructured":"Stevanin G, Giunti P, Belal GD, et al. De novo expansion of intermediate alleles in spinocerebellar ataxia 7. Hum Mol Genet 1998; 7:1809\u20131813.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR26","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0896-6273(01)00422-6","volume":"31","author":"AR La Spada","year":"2001","unstructured":"La Spada AR, Fu YH, Sopher BL, et al. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron 2001; 31:913\u2013927.","journal-title":"Neuron"},{"key":"BFcr201032_CR27","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/nn2011","volume":"10","author":"MJ Friedman","year":"2007","unstructured":"Friedman MJ, Shah AG, Fang ZH, et al. Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration. Nat Neurosci 2007; 10:1519\u20131528.","journal-title":"Nat Neurosci"},{"key":"BFcr201032_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/112.1.209","volume":"112","author":"G Sobue","year":"1989","unstructured":"Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A . X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 1989; 112:209\u2013232.","journal-title":"Brain"},{"key":"BFcr201032_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/brain\/awm289","volume":"131","author":"K Suzuki","year":"2008","unstructured":"Suzuki K, Katsuno M, Banno H, et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain 2008; 131:229\u2013239.","journal-title":"Brain"},{"key":"BFcr201032_CR30","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1086\/302578","volume":"65","author":"F Tanaka","year":"1999","unstructured":"Tanaka F, Reeves MF, Ito Y, et al. Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor-gene expression level. Am J Hum Genet 1999; 65:966\u2013973.","journal-title":"Am J Hum Genet"},{"key":"BFcr201032_CR31","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s00415-009-5212-5","volume":"256","author":"GR Soukup","year":"2009","unstructured":"Soukup GR, Sperfeld AD, Uttner I, et al. Frontotemporal cognitive function in X-linked spinal and bulbar muscular atrophy (SBMA): a controlled neuropsychological study of 20 patients. J Neurol 2009; 256:1869\u20131875.","journal-title":"J Neurol"},{"key":"BFcr201032_CR32","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1001\/archneur.59.12.1921","volume":"59","author":"AD Sperfeld","year":"2002","unstructured":"Sperfeld AD, Karitzky J, Brummer D, et al. X-linked bulbospinal neuronopathy. Arch Neurol 2002; 59:1921\u20131926.","journal-title":"Arch Neurol"},{"key":"BFcr201032_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1440-1789.2006.00670.x","volume":"26","author":"M Yamada","year":"2006","unstructured":"Yamada M, Shimohata M, Sato T, Tsuji S, Takahashi H . Polyglutamine disease: recent advances in the neuropathology of dentatorubralpallidoluysian atrophy. Neuropathology 2006; 26:346\u2013351.","journal-title":"Neuropathology"},{"key":"BFcr201032_CR34","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/dvdy.22063","volume":"238","author":"J Yu","year":"2009","unstructured":"Yu J, Ying M, Zhuang Y, et al. C-terminal deletion of the atrophin-1 protein results in growth retardation but not neurodegeneration in mice. Dev Dyn 2009; 238:2471\u20132478.","journal-title":"Dev Dyn"},{"key":"BFcr201032_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0896-6273(00)80839-9","volume":"24","author":"G Schilling","year":"1999","unstructured":"Schilling G, Wood JD, Duan K, et al. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron 1999; 24:275\u2013286.","journal-title":"Neuron"},{"key":"BFcr201032_CR36","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/nn1988","volume":"10","author":"C Lobsiger","year":"2007","unstructured":"Lobsiger C, Cleveland D . Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 2007; 10:1355\u20131360.","journal-title":"Nat Neurosci"},{"key":"BFcr201032_CR37","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ . Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 2005; 171:1001\u20131012.","journal-title":"J Cell Biol"},{"key":"BFcr201032_CR38","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1523\/JNEUROSCI.0116-08.2008","volume":"28","author":"SY Chou","year":"2008","unstructured":"Chou SY, Weng JY, Lai HL, et al. Expanded-polyglutamine Huntingtin protein suppresses the secretion and production of a chemokine (CCL5\/RANTES) by astrocytes. J Neurosci 2008; 28:3277\u20133290.","journal-title":"J Neurosci"},{"key":"BFcr201032_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1006\/exnr.1998.6778","volume":"150","author":"SK Singhrao","year":"1998","unstructured":"Singhrao SK, Thomas P, Wood DJ, et al. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: an investigation in Huntington's, Alzheimer's, and Pick's diseases. Exp Neurol 1998; 150:213\u2013222.","journal-title":"Exp Neurol"},{"key":"BFcr201032_CR40","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1016\/j.neuroimage.2009.10.015","volume":"49","author":"HD Rosas","year":"2009","unstructured":"Rosas HD, Lee SY, Bender A, et al. Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical \u201cdisconnection\u201d. Neuroimage 2009; 49:2995\u20133004.","journal-title":"Neuroimage"},{"key":"BFcr201032_CR41","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","volume":"17","author":"CE Wang","year":"2008","unstructured":"Wang CE, Tydlacka S, Orr AL, et al. Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease. Hum Mol Genet 2008; 17:2738\u20132751.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR42","doi-asserted-by":"publisher","first-page":"13285","DOI":"10.1523\/JNEUROSCI.4393-08.2008","volume":"28","author":"S Tydlacka","year":"2008","unstructured":"Tydlacka S, Wang CE, Wang X, Li S, Li XJ . Differential activities of the ubiquitin\u2013proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons. J Neurosci 2008; 28:13285\u201313295.","journal-title":"J Neurosci"},{"key":"BFcr201032_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ncpneuro0355","volume":"2","author":"N Maragakis","year":"2006","unstructured":"Maragakis N, Rothstein J . Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2006; 2:679\u2013689.","journal-title":"Nat Clin Pract Neurol"},{"key":"BFcr201032_CR44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","volume":"8","author":"JC Lievens","year":"2001","unstructured":"Lievens JC, Woodman B, Mahal A, et al. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis 2001; 8:807\u2013821.","journal-title":"Neurobiol Dis"},{"key":"BFcr201032_CR45","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/brain\/awf180","volume":"125","author":"PF Behrens","year":"2002","unstructured":"Behrens PF, Franz P, Woodman B, Lindenberg KS, Landwehrmeyer GB . Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 2002; 125:1908\u20131922.","journal-title":"Brain"},{"key":"BFcr201032_CR46","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","volume":"56","author":"T Arzberger","year":"1997","unstructured":"Arzberger T, Krampfl K, Leimgruber S, Weindl A . Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease \u2013 an in situ hybridization study. J Neuropathol Exp Neurol 1997; 56:440\u2013454.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFcr201032_CR47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","volume":"33","author":"B Hassel","year":"2008","unstructured":"Hassel B, Tessler S, Faull RL, Emson PC . Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem Res 2008; 33:232\u2013237.","journal-title":"Neurochem Res"},{"key":"BFcr201032_CR48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/hmg\/ddi067","volume":"14","author":"JC Lievens","year":"2005","unstructured":"Lievens JC, Rival T, Iche M, Chneiweiss H, Birman S . Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. Hum Mol Genet 2005; 14:713\u2013724.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR49","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S . Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci USA 2009; 106:22480\u201322485.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr201032_CR50","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/nn1750","volume":"10","author":"SK Custer","year":"2006","unstructured":"Custer SK, Garden GA, Gill N, et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci 2006; 10:1302\u20131311.","journal-title":"Nat Neurosci"},{"key":"BFcr201032_CR51","first-page":"570","volume":"20","author":"JL Ridet","year":"1997","unstructured":"Ridet JL, Malhotra SK, Privat A, Gage FH . Reactive astrocytes: cellular and molecular cues to biological function. TINS 1997; 20:570\u2013577.","journal-title":"TINS"},{"key":"BFcr201032_CR52","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1006\/meth.1996.0113","volume":"10","author":"M Brenner","year":"1996","unstructured":"Brenner M, Messing A . GFAP transgenic mice. Methods 1996; 10:351\u2013364.","journal-title":"Methods"},{"key":"BFcr201032_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nn2047","volume":"11","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka K, Chun SJ, Boillee S, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 2008; 11: 251\u2013253.","journal-title":"Nat Neurosci"},{"key":"BFcr201032_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","volume":"60","author":"E Sapp","year":"2001","unstructured":"Sapp E, Kegel KB, Aronin N, et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 2001; 60:161\u2013172.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFcr201032_CR55","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","volume":"23","author":"ZX Yu","year":"2003","unstructured":"Yu ZX, Li SH, Evans J, Pillarisetti A, Li H, Li XJ . Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J Neurosci 2003; 23:2193\u20132202.","journal-title":"J Neurosci"},{"key":"BFcr201032_CR56","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brainresbull.2006.10.029","volume":"72","author":"YF Tai","year":"2007","unstructured":"Tai YF, Pavese N, Gerhard A, et al. Imaging microglial activation in Huntington's disease. Brain Res Bull 2007; 72:148\u2013151.","journal-title":"Brain Res Bull"},{"key":"BFcr201032_CR57","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/jnr.20562","volume":"81","author":"S Kim","year":"2005","unstructured":"Kim S, de Vellis J . Microglia in health and disease. J Neurosci Res 2005; 81:302\u2013313.","journal-title":"J Neurosci Res"},{"key":"BFcr201032_CR58","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"35","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG . Reactive microglia are positive for HLA-DR in the subatantia nigra of Parkinson's and Alzheimer's disease brain. Neurology 1988; 35:1285\u20131291.","journal-title":"Neurology"},{"key":"BFcr201032_CR59","doi-asserted-by":"publisher","first-page":"e8025","DOI":"10.1371\/journal.pone.0008025","volume":"30","author":"H Moffitt","year":"2009","unstructured":"Moffitt H, McPhail GD, Woodman B, Hobbs C, Bates GP . Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease. PLoS One 2009; 30:e8025.","journal-title":"PLoS One"},{"key":"BFcr201032_CR60","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/archneur.1988.00520320068017","volume":"45","author":"DJ Lanska","year":"1988","unstructured":"Lanska DJ, Lanska MJ, Lavine L, Schoenberg BS . Conditions associated with Huntington's disease at death: a case-control study. Arch Neurol 1988; 45:878\u2013880.","journal-title":"Arch Neurol"},{"key":"BFcr201032_CR61","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.nbd.2006.09.016","volume":"25","author":"MJ Mihm","year":"2007","unstructured":"Mihm MJ, Amann DM, Schanbacher BL, Altschuld RA, Bauer JA, Hoyt KR . Cardiac dysfunction in the R6\/2 mouse model of Huntington's disease. Neurobiol Dis 2007; 25:297\u2013308.","journal-title":"Neurobiol Dis"},{"key":"BFcr201032_CR62","doi-asserted-by":"publisher","first-page":"821","DOI":"10.4161\/auto.6502","volume":"4","author":"J Pattison","year":"2008","unstructured":"Pattison J, Robbins J . Protein misfolding and cardiac disease: establishing cause and effect. Autophagy 2008; 4:821\u2013823.","journal-title":"Autophagy"},{"key":"BFcr201032_CR63","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.107.750232","volume":"117","author":"JS Pattison","year":"2008","unstructured":"Pattison JS, Sanbe A, Maloyan A, Osinska H, Klevitsky R, Robbins J . Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure. Circulation 2008; 117:2743\u20132751.","journal-title":"Circulation"},{"key":"BFcr201032_CR64","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/S0140-6736(72)91092-6","volume":"1","author":"S Podolsky","year":"1972","unstructured":"Podolsky S, Leopold N, Sax D . Increased frequency of diabetes mellitus in patients with Huntington's chorea. Lancet 1972; 1:1356\u20131358.","journal-title":"Lancet"},{"key":"BFcr201032_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","volume":"27","author":"LA Farrer","year":"1985","unstructured":"Farrer LA . Diabetes mellitus in Huntington's disease. Clin Genet 1985; 27:62\u201367.","journal-title":"Clin Genet"},{"key":"BFcr201032_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000212174","volume":"23","author":"S Podolsky","year":"1977","unstructured":"Podolsky S, Leopold N . Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease. Gerontology 1977; 23:55\u201363.","journal-title":"Gerontology"},{"key":"BFcr201032_CR67","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","volume":"11","author":"OA Andreassen","year":"2002","unstructured":"Andreassen OA, Dedeoglu A, Stanojevic V, et al. Huntington's disease of the endrocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression. Neurobiol Dis 2002; 11:410\u2013424.","journal-title":"Neurobiol Dis"},{"key":"BFcr201032_CR68","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/hmg\/ddi053","volume":"14","author":"M Bjorkqvist","year":"2005","unstructured":"Bjorkqvist M, Fex M, Renstr\u00f6m E, et al. The R6\/2 transgenic mouse models of Huntington's disease develops diabetes due to deficient \u03b2-cell mass and exocytosis. Hum Mol Genet 2005; 14:565\u2013574.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR69","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2826.2007.01629.x","volume":"20","author":"K Josefsen","year":"2008","unstructured":"Josefsen K, Nielsen MD, J\u00f8rgensen KH, et al. Impaired glucose tolerance in the R6\/1 transgenic mouse model of Huntington's disease. J Neuroendocrinol 2008; 20:165\u2013172.","journal-title":"J Neuroendocrinol"},{"key":"BFcr201032_CR70","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","volume":"8","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Dedeoglu A, Ferrante RJ, et al. Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiol Dis 2001; 8:479\u2013491.","journal-title":"Neurobiol Dis"},{"key":"BFcr201032_CR71","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","volume":"18","author":"J Phan","year":"2009","unstructured":"Phan J, Hickey M, Zhang P, Chesselet MF, Reue K . Adiposed tissue dysfunction tracks disease progression in two Huntington's disease mouse models. Hum Mol Genet 2009; 18:1006\u20131016.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR72","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","volume":"48","author":"RH Myers","year":"1991","unstructured":"Myers RH, Sax DS, Koroshetz WJ, et al. Factors associated with slow progression in Huntington's disease. Arch Neurol 1991; 48:800\u2013804.","journal-title":"Arch Neurol"},{"key":"BFcr201032_CR73","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/hmg\/10.2.145","volume":"10","author":"JN Fain","year":"2001","unstructured":"Fain JN, Del Mar NA, Meade CA, Reiner A, Goldowitz D . Abnormalities in the functioning of adipocytes from R6\/2 mice that are transgenic for the Huntington's disease mutation. Hum Mol Genet 2001; 10:145\u2013152.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR74","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1523\/JNEUROSCI.23-17-06956.2003","volume":"23","author":"SH Li","year":"2003","unstructured":"Li SH, Yu ZX, Li CL, et al. Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J Neurosci 2003; 23:6956\u20136964.","journal-title":"J Neurosci"},{"key":"BFcr201032_CR75","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1365-2826.2008.1730.x","volume":"20","author":"BA Henry","year":"2008","unstructured":"Henry BA, Clarke IJ . Adipose tissue hormones and the regulation of food intake. J Neuroendocrinol 2008; 20:842\u2013849.","journal-title":"J Neuroendocrinol"},{"key":"BFcr201032_CR76","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","volume":"59","author":"L Djouss\u00e9","year":"2002","unstructured":"Djouss\u00e9 L, Knowlton B, Cupples LA, Marder K, Shoulson I, Myers RH . Weight loss in early stage of Huntington's disease. Neurology 2002; 59:1325\u20131330.","journal-title":"Neurology"},{"key":"BFcr201032_CR77","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/ana.21788","volume":"66","author":"ST Lee","year":"2009","unstructured":"Lee ST, Chu K, Jung KH, et al. Slowed progression in models of Huntington disease by adipose stem cell transplantation. Ann Neurol 2009; 66:671\u2013681.","journal-title":"Ann Neurol"},{"key":"BFcr201032_CR78","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/hmg\/8.5.813","volume":"8","author":"K Sathasivam","year":"1999","unstructured":"Sathasivam K, Hobbs C, Turmaine M, et al. Formation of polyglutamine inclusions in non-CNS tissue. Hum Mol Genet 1999; 8:813\u2013822.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR79","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1111\/j.1460-9568.2004.03783.x","volume":"20","author":"RR Ribchester","year":"2004","unstructured":"Ribchester RR, Thomson D, Wood NI, et al. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation. Eur J Neurosci 2004; 20:3092\u20133114.","journal-title":"Eur J Neurosci"},{"key":"BFcr201032_CR80","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1093\/hmg\/ddi192","volume":"14","author":"A Strand","year":"2005","unstructured":"Strand A, Aragaki A, Shaw D, et al. Gene expression in Huntington's disease skeletal muscle: a potential biomarker. Hum Mol Genet 2005; 14:1863\u20131876.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR81","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 1999; 19:3248\u20133257.","journal-title":"J Neurosci"},{"key":"BFcr201032_CR82","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","volume":"11","author":"R Luthi-Carter","year":"2002","unstructured":"Luthi-Carter R, Hanson S, Strand A, et al. Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 2002; 11:1911\u20131926.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR83","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt P, Pineda VV, Torrence AE, et al. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab 2006; 4:349\u2013362.","journal-title":"Cell Metab"},{"key":"BFcr201032_CR84","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","volume":"18","author":"RK Chaturvedi","year":"2009","unstructured":"Chaturvedi RK, Adhihetty P, Shukla S, et al. Impaired PGC-1alpha function in muscle in Huntington's disease. Hum Mol Genet 2009; 18:3048\u20133065.","journal-title":"Hum Mol Genet"},{"key":"BFcr201032_CR85","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.nbd.2008.01.014","volume":"30","author":"N Masuda","year":"2008","unstructured":"Masuda N, Peng Q, Li Q, et al. Tiagabine is neuroprotective in the N171\u201382Q and R6\/2 mouse models of Huntington's disease. Neurobiol Dis 2008; 30:293\u2013302.","journal-title":"Neurobiol Dis"},{"key":"BFcr201032_CR86","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","volume":"20","author":"RJ Ferrante","year":"2000","unstructured":"Ferrante RJ, Andreassen OA, Jenkins BG, et al. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci 2000; 20:4389\u20134397.","journal-title":"J Neurosci"},{"key":"BFcr201032_CR87","first-page":"237","volume":"23","author":"B Martin","year":"2008","unstructured":"Martin B, Golden E, Keselman A, et al. Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body. Histol Histopathol 2008; 23:237\u2013250.","journal-title":"Histol Histopathol"},{"key":"BFcr201032_CR88","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","volume":"153","author":"BR Miller","year":"2008","unstructured":"Miller BR, Dorner JL, Shou M, et al. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6\/2 mouse. Neuroscience 2008; 153:329\u2013337.","journal-title":"Neuroscience"}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cr201032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cr201032","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cr201032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T06:12:37Z","timestamp":1649916757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cr201032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,16]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["BFcr201032"],"URL":"https:\/\/doi.org\/10.1038\/cr.2010.32","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,16]]},"assertion":[{"value":"16 March 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}